These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30967464)

  • 21. Infection of Hysterectomized Mice with Chlamydia muridarum and Chlamydia trachomatis.
    Yang C; Whitmire WM; Sturdevant GL; Bock K; Moore I; Caldwell HD
    Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28461392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.
    Li W; Murthy AK; Lanka GK; Chetty SL; Yu JJ; Chambers JP; Zhong G; Forsthuber TG; Guentzel MN; Arulanandam BP
    Vaccine; 2013 Nov; 31(48):5722-8. PubMed ID: 24096029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.
    Roshick C; Wood H; Caldwell HD; McClarty G
    Infect Immun; 2006 Jan; 74(1):225-38. PubMed ID: 16368976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The
    Meier K; Jachmann LH; Türköz G; Babu Sait MR; Pérez L; Kepp O; Valdivia RH; Kroemer G; Sixt BS
    mBio; 2023 Aug; 14(4):e0319022. PubMed ID: 37530528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice.
    Jupelli M; Guentzel MN; Meier PA; Zhong G; Murthy AK; Arulanandam BP
    J Immunol; 2008 Mar; 180(6):4148-55. PubMed ID: 18322226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homologues of the Chlamydia trachomatis and Chlamydia muridarum Inclusion Membrane Protein IncS Are Interchangeable for Early Development but Not for Inclusion Stability in the Late Developmental Cycle.
    Cortina ME; Derré I
    mSphere; 2023 Apr; 8(2):e0000323. PubMed ID: 36853051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The type I interferon receptor is not required for protection in the Chlamydia muridarum and HSV-2 murine super-infection model.
    Slade JA; Hall JV; Kintner J; Schoborg RV
    Pathog Dis; 2018 Nov; 76(8):. PubMed ID: 30321322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Minimal Replicon Enables Efficacious, Species-Specific Gene Deletion in Chlamydia and Extension of Gene Knockout Studies to the Animal Model of Infection Using Chlamydia muridarum.
    Fields KA; Bodero MD; Scanlon KR; Jewett TJ; Wolf K
    Infect Immun; 2022 Dec; 90(12):e0045322. PubMed ID: 36350146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlamydia muridarum plasmid induces mouse oviduct pathology by promoting chlamydial survival and ascending infection and triggering host inflammation.
    Hou S; Yue L; Xu R; Zhu C; Shan S; Wang H; Liu Q
    Eur J Dermatol; 2018 Oct; 28(5):628-636. PubMed ID: 30442635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydial interferon gamma immune evasion influences infection tropism.
    McClarty G; Caldwell HD; Nelson DE
    Curr Opin Microbiol; 2007 Feb; 10(1):47-51. PubMed ID: 17208039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Transposon Mutagenesis for Chlamydia muridarum.
    Wang Y; LaBrie SD; Carrell SJ; Suchland RJ; Dimond ZE; Kwong F; Rockey DD; Hefty PS; Hybiske K
    J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary Chlamydia muridarum challenge activates lung interstitial macrophages which correlate with IFN-γ production and infection control in mice.
    Gracey E; Baglaenko Y; Prayitno N; Van Rooijen N; Akram A; Lin A; Chiu B; Inman RD
    Eur J Immunol; 2015 Dec; 45(12):3417-30. PubMed ID: 26344246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease.
    O'Connell CM; Ingalls RR; Andrews CW; Scurlock AM; Darville T
    J Immunol; 2007 Sep; 179(6):4027-34. PubMed ID: 17785841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.
    Johansson M; Schön K; Ward M; Lycke N
    Infect Immun; 1997 Mar; 65(3):1032-44. PubMed ID: 9038313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum.
    O'Connell CM; AbdelRahman YM; Green E; Darville HK; Saira K; Smith B; Darville T; Scurlock AM; Meyer CR; Belland RJ
    Infect Immun; 2011 Mar; 79(3):1044-56. PubMed ID: 21199910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopathogenesis of genital Chlamydia infection: insights from mouse models.
    Dockterman J; Coers J
    Pathog Dis; 2021 Mar; 79(4):. PubMed ID: 33538819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
    Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182.
    Gupta R; Arkatkar T; Keck J; Koundinya GK; Castillo K; Hobel S; Chambers JP; Yu JJ; Guentzel MN; Aigner A; Christenson LK; Arulanandam BP
    Oncotarget; 2016 Oct; 7(40):64726-64742. PubMed ID: 27556515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of MicroRNA-155 in Chlamydia muridarum Infected lungs.
    Keck J; Chambers JP; Kancharla A; Bashir DH; Henley L; Schenkel K; Castillo K; Neal Guentzel M; Gupta R; Arulanandam BP
    Microbes Infect; 2020 Sep; 22(8):360-365. PubMed ID: 32084556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.